Health Condition 1: F209- Schizophrenia, unspecified
Conditions
Interventions
Intervention1: Giving Dexmedetomidine infusion: IV dose of Dexmedetomidine at 0.25 mcg/kg
T:- 10 minutes before administration of Succinylcholine till end of procedure.
Intervention2: Nil: Nil
Interv
Sponsors
BLDE SHRI BM PATIL MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE VIJAYAPURA
Eligibility
Inclusion criteria
Inclusion criteria: 1)Age between 18 and 60 years 2)ASA physical status 1 or 2 3)Planned for ECT with Succinylcholine administration 4)Willing and able to provide informed written consent
Exclusion criteria
Exclusion criteria: 1.allergy or hypersensitivity to Dexmedetomidine or succinylcholine History of neuromuscular disorders Presence of severe cardiovascular hepatic renal or respiratory disease bradycardia or hypotension Pregnant women Current use of medications affecting neuromuscular function
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasciculations ,myalgia ,HAEMODYNAMIC CHANGES will be observed and recorded after Succinylcholine administrationTimepoint: T1:- 5 mins after intervention T2:- During ECT T3:-5 mins after ECT 10 mins after ECT 20 mins after ECT 30 after ECT | — |
Secondary
| Measure | Time frame |
|---|---|
| Timepoint: | — |
Countries
India
Contacts
Public ContactDr Pratibha S D
Blde Shri bm Patil Medical College Hospital And Research Centre
Outcome results
None listed